Tuesday, May 15, 2012

Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 7


TABLE OF CONTENTS

Volume 37, Issue 7 (June 2012)

In this issue
Original Articles
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Neuropsychopharmacology Reviews
Highlighting Neurotherapeutics in 2012

Published each January as a special issue of Neuropsychopharmacology, the 2012 edition highlights Neurotherapeutics, with a thorough look at hot topics in this area and in-depth review articles.

Visit www.neuropsychopharmacologyreviews.org and gain access to the full list of reviews.
 

Original Articles

Top

Differential Effects of Cocaine on Dopamine Neuron Firing in Awake and Anesthetized Rats

Stanislav Koulchitsky, Benjamin De Backer, Etienne Quertemont, Corinne Charlier and Vincent Seutin

Neuropsychopharmacology 2012 37: 1559-1571; advance online publication, February 1, 2012; 10.1038/npp.2011.339

Abstract | Full Text

Evidence of IQ-Modulated Association Between ZNF804A Gene Polymorphism and Cognitive Function in Schizophrenia Patients

Min Chen, Zhansheng Xu, Jinguo Zhai, Xin Bao, Qiumei Zhang, Huang Gu, Qiuge Shen, Lina Cheng, Xiongying Chen, Keqin Wang, Xiaoxiang Deng, Feng Ji, Chuanxin Liu, Jun Li, Qi Dong and Chuansheng Chen

Neuropsychopharmacology 2012 37: 1572-1578; advance online publication, February 29, 2012; 10.1038/npp.2012.1

Abstract | Full Text

Loss of Environmental Enrichment Increases Vulnerability to Cocaine Addiction

Joëlle Nader, Chauvet Claudia, Rana El Rawas, Laure Favot, Mohamed Jaber, Nathalie Thiriet and Marcello Solinas

Neuropsychopharmacology 2012 37: 1579-1587; advance online publication, February 15, 2012; 10.1038/npp.2012.2

Abstract | Full Text

Prevention of Stress-Impaired Fear Extinction Through Neuropeptide S Action in the Lateral Amygdala

Frédéric Chauveau, Maren Denise Lange, Kay Jüngling, Jörg Lesting, Thomas Seidenbecher and Hans-Christian Pape

Neuropsychopharmacology 2012 37: 1588-1599; advance online publication, February 1, 2012; 10.1038/npp.2012.3

Abstract | Full Text

Physical Exercise and Antidepressants Enhance BDNF Targeting in Hippocampal CA3 Dendrites: Further Evidence of a Spatial Code for BDNF Splice Variants

Gabriele Baj, Valentina D'Alessandro, Laura Musazzi, Alessandra Mallei, Cesar R Sartori, Marina Sciancalepore, Daniela Tardito, Francesco Langone, Maurizio Popoli and Enrico Tongiorgi

Neuropsychopharmacology 2012 37: 1600-1611; advance online publication, February 8, 2012; 10.1038/npp.2012.5

Abstract | Full Text

Drug Intake is Sufficient, but Conditioning is not Necessary for the Emergence of Compulsive Cocaine Seeking After Extended Self-Administration

Sietse Jonkman, Yann Pelloux and Barry J Everitt

Neuropsychopharmacology 2012 37: 1612-1619; advance online publication, February 15, 2012; 10.1038/npp.2012.6

Abstract | Full Text

Olanzapine, but Not Fluoxetine, Treatment Increases Survival in Activity-Based Anorexia in Mice

Stephanie J Klenotich, Mariel P Seiglie, Matthew S McMurray, Jamie D Roitman, Daniel Le Grange, Priya Dugad and Stephanie C Dulawa

Neuropsychopharmacology 2012 37: 1620-1631; advance online publication, March 7, 2012; 10.1038/npp.2012.7

Abstract | Full Text

Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in Humans

Deepak Cyril D'Souza, Daniel J Fridberg, Patrick D Skosnik, Ashley Williams, Brian Roach, Nagendra Singh, Michelle Carbuto, Jacqueline Elander, Ashley Schnakenberg, Brian Pittman, R Andrew Sewell, Mohini Ranganathan and Daniel Mathalon

Neuropsychopharmacology 2012 37: 1632-1646; advance online publication, February 15, 2012; 10.1038/npp.2012.8

Abstract | Full Text

Selective DNA Methylation of BDNF Promoter in Bipolar Disorder: Differences Among Patients with BDI and BDII

Claudio D'Addario, Bernardo Dell'Osso, Maria Carlotta Palazzo, Beatrice Benatti, Licia Lietti, Elisabetta Cattaneo, Daniela Galimberti, Chiara Fenoglio, Francesca Cortini, Elio Scarpini, Beatrice Arosio, Andrea Di Francesco, Manuela Di Benedetto, Patrizia Romualdi, Sanzio Candeletti, Daniela Mari, Luigi Bergamaschini, Nereo Bresolin, Mauro Maccarrone and A Carlo Altamura

Neuropsychopharmacology 2012 37: 1647-1655; advance online publication, February 22, 2012; 10.1038/npp.2012.10

Abstract | Full Text

Chronic Corticosterone Exposure during Adolescence Reduces Impulsive Action but Increases Impulsive Choice and Sensitivity to Yohimbine in Male Sprague-Dawley Rats

Mary M Torregrossa, Maylene Xie and Jane R Taylor

Neuropsychopharmacology 2012 37: 1656-1670; advance online publication, February 15, 2012; 10.1038/npp.2012.11

Abstract | Full Text

Temporally Dependent Changes in Cocaine-Induced Synaptic Plasticity in the Nucleus Accumbens Shell are Reversed by D1-Like Dopamine Receptor Stimulation

Pavel I Ortinski, Fair M Vassoler, Gregory C Carlson and R Christopher Pierce

Neuropsychopharmacology 2012 37: 1671-1682; advance online publication, March 14, 2012; 10.1038/npp.2012.12

Abstract | Full Text

Pharmacogenetic Association of the Galanin Receptor (GALR1) SNP rs2717162 with Smoking Cessation

Allison B Gold, E Paul Wileyto, Adriana Lori, David Conti, Joseph F Cubells and Caryn Lerman

Neuropsychopharmacology 2012 37: 1683-1688; advance online publication, February 29, 2012; 10.1038/npp.2012.13

Abstract | Full Text

A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults

Barbara J Mason, Rebecca Crean, Vivian Goodell, John M Light, Susan Quello, Farhad Shadan, Kimberly Buffkins, Mark Kyle, Murali Adusumalli, Adnan Begovic and Santosh Rao

Neuropsychopharmacology 2012 37: 1689-1698; advance online publication, February 29, 2012; 10.1038/npp.2012.14

Abstract | Full Text

Dissociation of Hedonic Reaction to Reward and Incentive Motivation in an Animal Model of the Negative Symptoms of Schizophrenia

Ryan D Ward, Eleanor H Simpson, Vanessa L Richards, Gita Deo, Kathleen Taylor, John I Glendinning, Eric R Kandel and Peter D Balsam

Neuropsychopharmacology 2012 37: 1699-1707; advance online publication, March 14, 2012; 10.1038/npp.2012.15

Abstract | Full Text

Cocaine Self-Administration Produces Pharmacodynamic Tolerance: Differential Effects on the Potency of Dopamine Transporter Blockers, Releasers, and Methylphenidate

Mark J Ferris, Erin S Calipari, Yolanda Mateo, James R Melchior, David CS Roberts and Sara R Jones

Neuropsychopharmacology 2012 37: 1708-1716; advance online publication, March 7, 2012; 10.1038/npp.2012.17

Abstract | Full Text

Effects of Sustained Administration of Quetiapine Alone and in Combination with a Serotonin Reuptake Inhibitor on Norepinephrine and Serotonin Transmission

Olga Chernoloz, Mostafa El Mansari and Pierre Blier

Neuropsychopharmacology 2012 37: 1717-1728; advance online publication, February 29, 2012; 10.1038/npp.2012.18

Abstract | Full Text

Dopamine Modulates Reward System Activity During Subconscious Processing of Sexual Stimuli

Nicole Y L Oei, Serge ARB Rombouts, Roelof P Soeter, Joop M van Gerven and Stephanie Both

Neuropsychopharmacology 2012 37: 1729-1737; advance online publication, March 7, 2012; 10.1038/npp.2012.19

Abstract | Full Text

A Single Administration of Low-Dose Varenicline Saturates α4β2* Nicotinic Acetylcholine Receptors in the Human Brain

Shahrdad Lotfipour, Mark Mandelkern, Miguel Alvarez-Estrada and Arthur L Brody

Neuropsychopharmacology 2012 37: 1738-1748; advance online publication, March 7, 2012; 10.1038/npp.2012.20

Abstract | Full Text

Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors

Auxiliadora Aracil-Fernández, José M Trigo, María S García-Gutiérrez, Antonio Ortega-Álvaro, Alexander Ternianov, Daniela Navarro, Patricia Robledo, Pere Berbel, Rafael Maldonado and Jorge Manzanares

Neuropsychopharmacology 2012 37: 1749-1763; advance online publication, March 14, 2012; 10.1038/npp.2012.22

Abstract | Full Text

Frontal Theta Cordance Predicts 6-Month Antidepressant Response to Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression: A Pilot Study

James M Broadway, Paul E Holtzheimer, Matthew R Hilimire, Nathan A Parks, Jordan E DeVylder, Helen S Mayberg and Paul M Corballis

Neuropsychopharmacology 2012 37: 1764-1772; advance online publication, March 14, 2012; 10.1038/npp.2012.23

Abstract | Full Text

Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic Pathways

Áine T Behan, Magdalena Hryniewiecka, Colm M P O'Tuathaigh, Anthony Kinsella, Mary Cannon, Maria Karayiorgou, Joseph A Gogos, John L Waddington and David R Cotter

Neuropsychopharmacology 2012 37: 1773-1783; advance online publication, March 21, 2012; 10.1038/npp.2012.24

Abstract | Full Text

Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease

Giuseppe D'Agostino, Roberto Russo, Carmen Avagliano, Claudia Cristiano, Rosaria Meli and Antonio Calignano

Neuropsychopharmacology 2012 37: 1784-1792; advance online publication, March 14, 2012; 10.1038/npp.2012.25

Abstract | Full Text

Corrigendum

Top

Behavioral and Neural Analysis of GABA in the Acquisition, Consolidation, Reconsolidation, and Extinction of Fear Memory

Steve R Makkar, Shirley Q Zhang and Jacquelyn Cranney

Neuropsychopharmacology 2012 37: 1793-1794; 10.1038/npp.2012.16

Full Text

Advertisement
Neuropsychopharmacology Brainpod: Neurotherapeutics

The brain is a daunting therapeutic challenge. This year's edition of Neuropsychopharmacology Reviews provides an update on treatments for brain disorders ranging from schizophrenia to neurodegeneration. Join Kerri Smith as she talks to Gwenn Smith, editor of this year's volume, about current therapies such as drugs, electrical stimulation and cognitive therapies, and the future of neurotherapeutics in an era of uncertain funding.

Visit www.nature.com/npp/podcast
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: